AGP Executive Report
Last update: 7 hours agoBiotech Earnings Roundup: Cellectis, Cognition Therapeutics, Solid Biosciences, Structure Therapeutics, Zymeworks, SpyGlass Pharma, Verrica, Relmada, NextCure, IN8bio, Agomab, Xenon, Voyager, and Replimune all posted Q2 results and updates, with notable FDA moves including Replimune’s accelerated approval for advanced melanoma and Cellectis’ RMAT designation for lasme-cel. Publishing & Adaptations: VIZ Media teamed with The Gotham Group to develop film/TV projects from VIZ Originals and RWBY. Books & Culture: Karin Slaughter’s new North Falls thriller lands Aug. 11; plus fresh summer reading picks and book-club announcements. AI & Reading Debate: A study claims people rate AI-written stories higher, while booksellers warn about AI training’s impact on used books. Community & Libraries: Louisiana Readers’ Choice nominees for K-12 were announced, and youth theatre camp Shine Summer Theatre Camp wrapped with performances. Science for Readers: A new marmoset genome study aims to sharpen Alzheimer’s/Parkinson’s research.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.